SynthesisMedicine2016

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.

Jun-Rui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.